Efficacy and safety of FOLFIRINOX in advanced cholangiocarcinoma.

被引：2
|
作者：
Kim, Byung Moon
Armenio, Vincent Anthony
机构：
[1] Roger Williams Med Ctr, Warwick, RI USA
[2] Boston Univ, Roger Williams Med Ctr, Providence, RI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15620
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Real-world testing, treatment patterns, and outcomes following liquid biopsy in advanced cholangiocarcinoma.
    Mahipal, Amit
    Clemens, Keelia M.
    Liao, Jiemin
    Weipert, Caroline M.
    Bucheit, Leslie
    Khushman, Moh'd M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 455 - 455
  • [32] Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
    Silverman, Ian M.
    Murugesan, Karthikeyan
    Lihou, Christine F.
    Feliz, Luis
    Frampton, Garrett M.
    Newton, Robert C.
    Tada, Hiroomi
    Albacker, Lee A.
    Burn, Timothy C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Outcome of aggressive surgical therapy for peripheral cholangiocarcinoma.
    Casavilla, FA
    Iwatsuki, S
    Todo, S
    Madariaga, J
    Lee, R
    Marsh, W
    Dvorchik, I
    Starzl, TE
    HEPATOLOGY, 1996, 24 (04) : 260 - 260
  • [34] The effect of socioeconomic factors on the outcome of intrahepatic cholangiocarcinoma.
    Sellers, Cortlandt
    Ludwig, Johannes M.
    Uhlig, Johannes
    Stein, Stacey
    Lacy, Jill
    Kim, Hyun S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [35] Modulation of Fas expression: A potential therapy for cholangiocarcinoma.
    Jhala, N
    Pan, G
    Ahn, EY
    Vickers, SM
    McDonald, JM
    MODERN PATHOLOGY, 2001, 14 (01) : 197A - 197A
  • [36] Intrahepatic cholangiocarcinoma. Results after 84 resections
    Neeff, H. P.
    Holzner, P. A.
    Menzel, M.
    Bronsert, P.
    Klock, A.
    Lang, S. A.
    Fichtner-Feigl, S.
    Hopt, U. T.
    Makowiec, F.
    CHIRURG, 2018, 89 (05): : 374 - 380
  • [37] Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
    Tang, Tin-Yun
    De Armas, Anaemy Danner
    Ross, Jeffrey S.
    Pavlick, Dean C.
    Sharaf, Radwa
    Kaplan, Benjamin G.
    Sokol, Ethan
    Ahnert, Jordi Rodon
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 599 - 599
  • [38] Expression of cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Jin, YM
    Joo, HJ
    Lee, KB
    Wang, HJ
    HEPATOLOGY, 1999, 30 (04) : 277A - 277A
  • [39] Role of lymph node dissection for intrahepatic cholangiocarcinoma.
    Hibi, Taizo
    Takemura, Yusuke
    Itano, Osamu
    Shinoda, Masahiro
    Kitago, Minoru
    Abe, Yuta
    Yagi, Hiroshi
    Kitagawa, Yuko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [40] Genomic predictors of sensitivity to chemotherapy and immunotherapy in cholangiocarcinoma.
    Patel, Riya Jayesh
    Rosario, Spencer
    Sonti, Sahithi
    Kapoor, Ankita
    Vadehra, Deepak
    Mukherjee, Sarbajit
    Thanikachalam, Kannan
    Iyer, Renuka V.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 540 - 540
12345